PET/CT findings in gastric cancer: Potential advantages and current limitations

Saadet Atay-Rosenthal; Richard L. Wahl; Elliot K. Fishman

doi:10.2217/iim.12.5

PET/CT findings in gastric cancer: Potential advantages and current limitations

Saadet Atay-Rosenthal, Richard L. Wahl, Elliot K. Fishman

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

¹⁸F-fluorodeoxyglucose ( ¹⁸F-FDG) as a substrate for tumors with high glucose metabolism has been the most commonly used ¹⁸F-FDG-PET radiopharmaceutical in oncologic imaging. However, the usefulness of ¹⁸F-FDG-PET in gastric cancer has not yet been fully established. The intent of this review is to help to better understand the impact of ¹⁸F-FDG-PET on the imaging of gastric cancer, to offer a greater understanding of how gastric malignancies may present and be recognized on ¹⁸F-FDG-PET and to assess the complementary value of PET/CT in gastric cancer staging.

Original language	English
Pages (from-to)	241-250
Number of pages	10
Journal	Imaging in Medicine
Volume	4
Issue number	2
DOIs	https://doi.org/10.2217/iim.12.5
State	Published - Apr 2012

Keywords

F-FDG-PET
F-fluorodeoxyglucose
PET/CT
TNM staging
gastric cancer staging
gastric carcinoma

Access to Document

10.2217/iim.12.5

Cite this

@article{9c63f259256b4e30b99a203f5c31db8d,

title = "PET/CT findings in gastric cancer: Potential advantages and current limitations",

abstract = "18F-fluorodeoxyglucose ( 18F-FDG) as a substrate for tumors with high glucose metabolism has been the most commonly used 18F-FDG-PET radiopharmaceutical in oncologic imaging. However, the usefulness of 18F-FDG-PET in gastric cancer has not yet been fully established. The intent of this review is to help to better understand the impact of 18F-FDG-PET on the imaging of gastric cancer, to offer a greater understanding of how gastric malignancies may present and be recognized on 18F-FDG-PET and to assess the complementary value of PET/CT in gastric cancer staging.",

keywords = "F-FDG-PET, F-fluorodeoxyglucose, PET/CT, TNM staging, gastric cancer staging, gastric carcinoma",

author = "Saadet Atay-Rosenthal and Wahl, {Richard L.} and Fishman, {Elliot K.}",

year = "2012",

month = apr,

doi = "10.2217/iim.12.5",

language = "English",

volume = "4",

pages = "241--250",

journal = "Imaging in Medicine",

issn = "1755-5191",

number = "2",

}

TY - JOUR

T1 - PET/CT findings in gastric cancer

T2 - Potential advantages and current limitations

AU - Atay-Rosenthal, Saadet

AU - Wahl, Richard L.

AU - Fishman, Elliot K.

PY - 2012/4

Y1 - 2012/4

N2 - 18F-fluorodeoxyglucose ( 18F-FDG) as a substrate for tumors with high glucose metabolism has been the most commonly used 18F-FDG-PET radiopharmaceutical in oncologic imaging. However, the usefulness of 18F-FDG-PET in gastric cancer has not yet been fully established. The intent of this review is to help to better understand the impact of 18F-FDG-PET on the imaging of gastric cancer, to offer a greater understanding of how gastric malignancies may present and be recognized on 18F-FDG-PET and to assess the complementary value of PET/CT in gastric cancer staging.

AB - 18F-fluorodeoxyglucose ( 18F-FDG) as a substrate for tumors with high glucose metabolism has been the most commonly used 18F-FDG-PET radiopharmaceutical in oncologic imaging. However, the usefulness of 18F-FDG-PET in gastric cancer has not yet been fully established. The intent of this review is to help to better understand the impact of 18F-FDG-PET on the imaging of gastric cancer, to offer a greater understanding of how gastric malignancies may present and be recognized on 18F-FDG-PET and to assess the complementary value of PET/CT in gastric cancer staging.

KW - F-FDG-PET

KW - F-fluorodeoxyglucose

KW - PET/CT

KW - TNM staging

KW - gastric cancer staging

KW - gastric carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84860209052&partnerID=8YFLogxK

U2 - 10.2217/iim.12.5

DO - 10.2217/iim.12.5

M3 - Review article

AN - SCOPUS:84860209052

SN - 1755-5191

VL - 4

SP - 241

EP - 250

JO - Imaging in Medicine

JF - Imaging in Medicine

IS - 2

ER -

PET/CT findings in gastric cancer: Potential advantages and current limitations

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this